Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1990 Jun;53(6):466–471. doi: 10.1136/jnnp.53.6.466

The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.

C J Vecht 1, C J Avezaat 1, W L van Putten 1, W M Eijkenboom 1, S Z Stefanko 1
PMCID: PMC1014204  PMID: 2166137

Abstract

A retrospective analysis was performed on 66 patients with anaplastic astrocytoma (AA) and 177 patients with glioblastoma multiforme (GM). The prognostic importance of age, performance status, tumour location, extent of surgery and radiation treatment was studied. Radiation therapy gave a significant improvement in survival in both AA (p less than 0.003) and GM (p less than 0.002), but was given only to patients in a good neurological condition. Both younger age (p less than 0.003), and good preoperative performance status (p less than 0.002) were associated with a longer survival in AA, but not in GM. Extensive surgery was correlated with a better immediate postoperative performance, a lower one-month mortality rate and a longer survival, in both AA and GM. There was no relationship between preoperative neurological function status and the extent of surgery. Because of the retrospective nature of this study, the conclusion is that performing extensive surgery instead of limited surgery does not lead to more deterioration in postoperative neurological function.

Full text

PDF
466

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammirati M., Vick N., Liao Y. L., Ciric I., Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery. 1987 Aug;21(2):201–206. doi: 10.1227/00006123-198708000-00012. [DOI] [PubMed] [Google Scholar]
  2. Andreou J., George A. E., Wise A., de Leon M., Kricheff I. I., Ransohoff J., Foo S. H. CT prognostic criteria of survival after malignant glioma surgery. AJNR Am J Neuroradiol. 1983 May-Jun;4(3):488–490. [PMC free article] [PubMed] [Google Scholar]
  3. Borgelt B., Gelber R., Kramer S., Brady L. W., Chang C. H., Davis L. W., Perez C. A., Hendrickson F. R. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1–9. doi: 10.1016/0360-3016(80)90195-9. [DOI] [PubMed] [Google Scholar]
  4. Chang C. H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J. S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 1983 Sep 15;52(6):997–1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  5. Ciric I., Ammirati M., Vick N., Mikhael M. Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery. 1987 Jul;21(1):21–26. doi: 10.1227/00006123-198707000-00005. [DOI] [PubMed] [Google Scholar]
  6. FRANKEL S. A., GERMAN W. J. Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment. J Neurosurg. 1958 Sep;15(5):489–503. doi: 10.3171/jns.1958.15.5.0489. [DOI] [PubMed] [Google Scholar]
  7. Fadul C., Wood J., Thaler H., Galicich J., Patterson R. H., Jr, Posner J. B. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology. 1988 Sep;38(9):1374–1379. doi: 10.1212/wnl.38.9.1374. [DOI] [PubMed] [Google Scholar]
  8. Green S. B., Byar D. P., Walker M. D., Pistenmaa D. A., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., Mealey J., Jr, Odom G. L. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983 Feb;67(2):121–132. [PubMed] [Google Scholar]
  9. Jelsma R., Bucy P. C. The treatment of glioblastoma multiforme of the brain. J Neurosurg. 1967 Nov;27(5):388–400. doi: 10.3171/jns.1967.27.5.0388. [DOI] [PubMed] [Google Scholar]
  10. Kristiansen K., Hagen S., Kollevold T., Torvik A., Holme I., Nesbakken R., Hatlevoll R., Lindgren M., Brun A., Lindgren S. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer. 1981 Feb 15;47(4):649–652. doi: 10.1002/1097-0142(19810215)47:4<649::aid-cncr2820470405>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  11. Laws E. R., Jr, Taylor W. F., Clifton M. B., Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg. 1984 Oct;61(4):665–673. doi: 10.3171/jns.1984.61.4.0665. [DOI] [PubMed] [Google Scholar]
  12. Nelson D. F., Nelson J. S., Davis D. R., Chang C. H., Griffin T. W., Pajak T. F. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurooncol. 1985;3(2):99–103. doi: 10.1007/BF02228884. [DOI] [PubMed] [Google Scholar]
  13. Nelson J. S., Tsukada Y., Schoenfeld D., Fulling K., Lamarche J., Peress N. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer. 1983 Aug 1;52(3):550–554. doi: 10.1002/1097-0142(19830801)52:3<550::aid-cncr2820520327>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  14. ROTH J. G., ELVIDGE A. R. Glioblastoma multiforme: a clinical survey. J Neurosurg. 1960 Jul;17:736–750. doi: 10.3171/jns.1960.17.4.0736. [DOI] [PubMed] [Google Scholar]
  15. Walker M. D., Alexander E., Jr, Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Norrell H. A., Owens G., Ransohoff J., Wilson C. B. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978 Sep;49(3):333–343. doi: 10.3171/jns.1978.49.3.0333. [DOI] [PubMed] [Google Scholar]
  16. Walker M. D., Green S. B., Byar D. P., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980 Dec 4;303(23):1323–1329. doi: 10.1056/NEJM198012043032303. [DOI] [PubMed] [Google Scholar]
  17. Weir B. The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4. J Neurosurg. 1973 Apr;38(4):448–452. doi: 10.3171/jns.1973.38.4.0448. [DOI] [PubMed] [Google Scholar]
  18. Wroe S. J., Foy P. M., Shaw M. D., Williams I. R., Chadwick D. W., West C., Towns G. Differences between neurological and neurosurgical approaches in the management of malignant brain tumours. Br Med J (Clin Res Ed) 1986 Oct 18;293(6553):1015–1018. doi: 10.1136/bmj.293.6553.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yamashita T., Kuwabara T. Estimation of rate of growth of malignant brain tumors by computed tomography scanning. Surg Neurol. 1983 Dec;20(6):464–470. doi: 10.1016/0090-3019(83)90029-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES